Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.55 is 295% above its 5-year average of 0.64, near the high end of its 5-year range (0.00–2.55).
As of the fiscal period ended Tuesday, June 30, 2026. 15.86% above its 12-month average of 2.20.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 2.55.
CURRENT RATIO
2.55
CURRENT RATIO AVG TTM
2.20
CURRENT RATIO AVG 3Y
1.03
CURRENT RATIO AVG 5Y
0.64
CURRENT RATIO AVG 10Y
0.03
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+15.86%
CURRENT VS 3Y AVG
+147.79%
CURRENT VS 5Y AVG
+295.29%
CURRENT VS 10Y AVG
+9902.74%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.74
median of 856 covered companies
CURRENT VS SECTOR MEDIAN
-31.82%
vs the sector median at left
Market Cap
$1.11M
Current Ratio
3.86
TTM Avg
3.42
3Y Avg
2.60
5Y Avg
2.60
Market Cap
$1.03M
Current Ratio
7.99
TTM Avg
0.13
3Y Avg
1.02
5Y Avg
1.02
Market Cap
$1.45M
Current Ratio
0.66
TTM Avg
1.48
3Y Avg
0.74
5Y Avg
0.53
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | $1.18M | 2.55 | 2.20 | 1.03 | 0.64 |
| IM Cannabis Corp. (IMCC)vs › | $1.13M | 0.56 | 0.67 | 0.76 | 1.51 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | 3.86 | 3.42 | 2.60 | 2.60 |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | 4.31 | 1.47 | 1.08 | 7.17 |
| NewcelX Ltd. (NCEL)vs › | $1.32M | 0.32 | 1.73 | 1.61 | 1.47 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | 7.99 | 0.13 | 1.02 | 1.02 |
| Genprex, Inc. (GNPX)vs › | $1.34M | 6.77 | 2.33 | 3.65 | 17.91 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | 3.00 | 0.80 | 7.12 | 9.62 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.45M | 0.66 | 1.48 | 0.74 | 0.53 |
| INVO Fertility, Inc. (IVF)vs › | $1.44M | 0.71 | 0.17 | 0.17 | 1.72 |
Current Ratio
2.55
Quick Ratio
2.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.55 |
| 2026-03-31 | 2.37 |
| 2025-12-31 | 2.13 |
| 2025-09-30 | 2.45 |
| 2025-06-30 | 1.50 |
| 2025-03-31 | 2.24 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.01 |
| 2024-06-30 | 0.01 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.06 |
| 2023-09-30 | 0.05 |
| 2023-06-30 | 0.01 |
| 2023-03-31 | 0.03 |
| 2022-12-31 | 0.02 |
| 2022-09-30 | 0.01 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.05 |
| 2021-12-31 | 0.03 |
| 2021-09-30 | 0.02 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.01 |
| 2020-12-31 | 0.01 |
| 2020-09-30 | 0.02 |
| 2020-06-30 | 0.02 |
| 2020-03-31 | 0.01 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.03 |
| 2019-06-30 | 0.02 |
| 2019-03-31 | 0.07 |
| 2018-12-31 | 0.08 |
| 2018-09-30 | 0.01 |
| 2018-06-30 | 0.01 |
| 2018-03-31 | 0.01 |
| 2017-12-31 | 0.02 |
| 2017-09-30 | 0.02 |
| 2017-06-30 | 0.01 |
| 2017-03-31 | 0.01 |
| 2016-12-31 | 0.03 |
| 2016-09-30 | 0.08 |
| 2016-06-30 | 0.12 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
